Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lazarus

Showing results (341-350 of 434) with videos related to

Pageof 44
Sort By:
JHEP Reports : Innovation in Hepatology|September 23, 2024
Implementing a new HCV model of care for people who use drugsAndrea Herranz Mochales, Camila A Picchio, Aina Nicolàs, et al.
The International Journal on Drug Policy|October 6, 2021
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugsJason Grebely, Alexandra B Collins, Andreea Adelina Artenie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2024
Racial and ethnic disparities in the natural history of alcohol-associated liver disease in the United StatesGustavo Ayares, Luis Antonio Díaz, Eduardo Fuentes-López, et al.
Nature Medicine|April 29, 2024
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023Jeffrey V Lazarus, Trenton M White, Katarzyna Wyka, et al.
The Lancet. Gastroenterology & Hepatology|March 12, 2022
A call for advocacy and patient voice to eliminate hepatitis B virus infectionPhilippa C Matthews, Kathryn Jack, Su Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2018
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems frameworkEmma Day, Margaret Hellard, Carla Treloar, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2026
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-managementXiao-Dong Zhou, Jeffrey V Lazarus, Chayakrit Krittanawong, et al.
BMC Infectious Diseases|September 26, 2014
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitisJeffrey V Lazarus, Jens Lundgren, Jordi Casabona, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 26, 2021
HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019Annemarie Rinder Stengaard, Lauren Combs, Virginie Supervie, et al.
Pageof 44

Showing results (341-350 of 434) with videos related to

Sort By:
Pageof 44
JHEP Reports : Innovation in Hepatology|September 23, 2024
Implementing a new HCV model of care for people who use drugsAndrea Herranz Mochales, Camila A Picchio, Aina Nicolàs, et al.
The International Journal on Drug Policy|October 6, 2021
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugsJason Grebely, Alexandra B Collins, Andreea Adelina Artenie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2024
Racial and ethnic disparities in the natural history of alcohol-associated liver disease in the United StatesGustavo Ayares, Luis Antonio Díaz, Eduardo Fuentes-López, et al.
Nature Medicine|April 29, 2024
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023Jeffrey V Lazarus, Trenton M White, Katarzyna Wyka, et al.
The Lancet. Gastroenterology & Hepatology|March 12, 2022
A call for advocacy and patient voice to eliminate hepatitis B virus infectionPhilippa C Matthews, Kathryn Jack, Su Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2018
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems frameworkEmma Day, Margaret Hellard, Carla Treloar, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2026
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-managementXiao-Dong Zhou, Jeffrey V Lazarus, Chayakrit Krittanawong, et al.
BMC Infectious Diseases|September 26, 2014
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitisJeffrey V Lazarus, Jens Lundgren, Jordi Casabona, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 26, 2021
HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019Annemarie Rinder Stengaard, Lauren Combs, Virginie Supervie, et al.
Pageof 44